Wits Health Consortium (Pty) Ltd
21
1
3
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
4.8%
1 terminated/withdrawn out of 21 trials
90.9%
+4.4% vs industry average
29%
6 trials in Phase 3/4
0%
0 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (21)
Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)
Role: collaborator
Developing a Resiliency Intervention to Support Healthcare Workers Engaged in the Provision of HIV Care
Role: collaborator
ValgaNciclovIR for CMV Viraemia in AdvaNced HIV diseAse
Role: lead
Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)
Role: collaborator
Triage Test for All Oral DR-TB Regimen (TRiAD Study)
Role: collaborator
A Pan-TB Regimen Targeting Host and Microbe
Role: collaborator
The Vitality Mammography Messaging Study
Role: lead
Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa
Role: collaborator
TB-CAPT MTB/XDR Study
Role: collaborator
Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care
Role: lead
Patient-reported Experiences and Quality of Life Outcomes in the TB-PRACTECAL Clinical Trial
Role: collaborator
Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s)
Role: collaborator
Economic Evaluation of New MDR TB Regimens
Role: collaborator
Implementing Oral (Event-driven and Daily) and Long-acting Pre-Exposure Prophylaxis in Mobile Men in Sub-Saharan Africa
Role: collaborator
Testing the Effectiveness of Different Messaging Approaches to Increase Doctor Visits Amongst Individuals With Risk Factors for Diabetes
Role: lead
The CHAPS Trial: Combined HIV Adolescent PrEP and Prevention
Role: lead
PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19
Role: lead
Sisonke 2 - A COVID-19 Vaccine Boost Open Label Study.
Role: lead
Sisonke (Together): OPEN LABEL TRIAL COVID-19
Role: lead
PRACTECAL-PKPD Sub Study
Role: collaborator